| Literature DB >> 31425885 |
Sarah Inwood1, Laura Abaandou2, Michael Betenbaugh3, Joseph Shiloach4.
Abstract
Stable cell lines can continuously produce a recombinant protein without the need to repeatedly engineer the genome. In a previous study HIPK1, Homeodomain-interacting Protein Kinase 1, was found to be a target of the microRNA miR-22 that, when repressed, improved expression of both an intracellular and a secreted protein. In this report, HEK293 cells stably over-expressing miR-22 were compared with HEK293 with knockout of HIPK1, executed by CRISPR/Cas9, for their ability to improve recombinant protein expression. In this model case of luciferase, over-expression of miR-22 improved overall activity 2.4-fold while the HIPK1 knockout improved overall activity 4.7-fold.Entities:
Keywords: CRISPR/Cas9; HIPK1; Protein expression; Stable; miR-22
Mesh:
Substances:
Year: 2019 PMID: 31425885 PMCID: PMC6759407 DOI: 10.1016/j.nbt.2019.08.004
Source DB: PubMed Journal: N Biotechnol ISSN: 1871-6784 Impact factor: 5.079